Marshall Wace, LLP Ginkgo Bioworks Holdings, Inc. Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $577,129 - $909,251	544,462 New	544,462 $631,000
Q2 2022 Aug 15, 2022	SELL	$2.2 - $4.2 $1.93 Million - $3.68 Million	-875,207 Reduced 69.31%	387,518 $924,000
Q1 2022 May 16, 2022	BUY	$2.83 - $8.69 $3.27 Million - $10 Million	1,154,467 Added 1066.4%	1,262,725 $5.09 Million
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $899,623 - $1.62 Million	108,258 New	108,258 $899,000

343

925M

1.04M

2.23M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.5B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.